CD44, EGFR and p16 expressions in oropharyngeal squamous cell cancer patients treated by IMRT.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14740%2F18%3A00106461" target="_blank" >RIV/00216224:14740/18:00106461 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/S0167-8140(18)32601-X" target="_blank" >http://dx.doi.org/10.1016/S0167-8140(18)32601-X</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S0167-8140(18)32601-X" target="_blank" >10.1016/S0167-8140(18)32601-X</a>
Alternative languages
Result language
angličtina
Original language name
CD44, EGFR and p16 expressions in oropharyngeal squamous cell cancer patients treated by IMRT.
Original language description
The aim of this study was to analyse the expression of epidermal growth factor receptor (EGFR), cluster of differentiation- 44 (CD44) and p16 in patients with oropharyngeal squamous cell carcinoma (OSCC) and correlate the expression profiles with radiation treatment outcomes.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů